PRINEOS
Aldo Poli is an accomplished professional with extensive experience in leadership and clinical research. Currently serving as President at PRINEOS since January 2022, Aldo previously held the role of Clinical Research Methodology Consultant from April 2021 to January 2022. Prior to this, Aldo was the Managing Director and CEO of OPIS s.r.l. from May 1999 to April 2021 and worked at Poli Industria Chimica from 1984 to 1998 as Dirigente - Responsabile del Servizio di Statistica e Biometria. Aldo Poli holds a degree from Università degli Studi di Milano and completed education at Liceo Classico Gonzaga in Milano.
This person is not in the org chart
This person is not in any teams
PRINEOS
PRINEOS is both a CRO and strategic consulting company whose goal is to improve and innovate clinical research in the healthcare industry. We provide services on: • Biostatistics (study design, sample size calculation, advanced statistical methodology, trainings, etc.) • Medical Affairs (identification of medical needs and data gaps, study concept sheet development, medical writing, , trainings, management of KOLs, Steering Committees, etc.) • Clinical Operations (project management, site/country feasibility, management of enrolment/retention, study documentation management, monitoring, etc.) • Legal Affairs (regulatory strategy and support, Clinical Trial Agreements’ management, legal and privacy consultancy services, trainings, etc.). Moreover, our Regulatory Unit assists Medical Devices manufacturers in the transition towards MDR, including services such as Technical Documentation drafting & review, CEP/CER, Risk Analysis, PMS/PMFC, SSCP, BEP/BER and ADME test, MDSAP and interface with Notified Bodies. To learn more, visit www.prineos.com